LLY
Eli Lilly and Company
- Free cash flow, 2025
- $9.0B
- YoY, 2025
- +138.6%
- 5-year CAGR
- +11.9%
- 10-year CAGR
- +16.8%
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $9.0B | +138.6% |
| 2024 | $3.8B | +374.7% |
| 2023 | $792M | −86.2% |
| 2022 | $5.7B | −5.4% |
| 2021 | $6.1B | +18.5% |
| 2020 | $5.1B | +34.4% |
| 2019 | $3.8B | −11.9% |
| 2018 | $4.3B | −5.0% |
| 2017 | $4.5B | +19.0% |
| 2016 | $3.8B | +100.9% |
| 2015 | $1.9B | −42.4% |
| 2014 | $3.3B | −30.2% |
| 2013 | $4.7B | +7.4% |
| 2012 | $4.4B | −33.0% |
| 2011 | $6.6B | +6.5% |
| 2010 | $6.2B | +72.6% |
| 2009 | $3.6B | −43.8% |
| 2008 | $6.3B | +55.9% |
| 2007 | $4.1B | — |